Oral Versus Intravenous Tranexamic Acid

Status Completed

Clinical Trial Summary

The goal of this randomized clinical control trial is to determine whether oral TXA dosing in THA/TKA result in more blood loss and more transfusions compared to IV TXA dosing in patients undergoing THA/TKA under neuraxial anesthesia. The main questions it aims to answer are: Does oral TXA dosing in THA/TKA result in more blood loss compared to IV TXA dosing? Does oral TXA dosing in THA/TKA result in more transfusions compared to IV TXA dosing? Participants will be randomly assigned to either get the Oral TXA (1950mg) or the IV TXA (1g) on their day of surgery. Researchers will compare these groups to see if any differences emerged. 200 THA patients (100 Oral, 100 IV), 200 TKA patients (100 oral, 100 IV).

Clinical Trial Description

Tranexamic acid (TXA) is an antifibrinolytic medication used to reduce bleeding in a variety of medical settings. The use of TXA in total hip arthroplasty (THA) and total knee arthroplasty (TKA) has resulted in dramatic decreases in operative blood loss and transfusion rates, revolutionizing the field of arthroplasty. The use of TXA, now common, has made autologous blood donation programs largely obsolete. Additionally, it has made perioperative blood transfusion uncommon. While AAOS guidelines suggest that all three available preparations of TXA (oral, IV, topical) are effective, preferred route of dosing varies by provider and institution. These preferences are based on habit, understanding of pharmacodynamics, and logistical issues regarding effective dosing. Oral TXA is the cheapest option, but some surgeons prefer IV dosing due to concerns regarding efficacy and controlled dosing. In this study, we seek to compare the efficacy of a single pre-op oral dose of TXA to a single pre-op IV dose of TXA. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04089865
Study type	Interventional
Source	Hospital for Special Surgery, New York
Contact
Status	Completed
Phase	Phase 4
Start date	September 17, 2019
Completion date	November 10, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04588350` - Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery	N/A
Completed	`NCT05426564` - Exploratory Assessment of the Quantra® System in Adult ECMO Patients
Active, not recruiting	`NCT05492214` - The Effect of Time Window for Umbilical Cord Clamping During Cesareans on Offspring Hemoglobin and Maternal Blood Loss	N/A
Withdrawn	`NCT05518279` - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures	Phase 3
Enrolling by invitation	`NCT02910115` - Cooling the Uterus in C-section After Dysfunctional Labor	N/A
Completed	`NCT02569658` - Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty	N/A
Completed	`NCT01048658` - Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures	Phase 4
Terminated	`NCT02908516` - Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures	Phase 4
Recruiting	`NCT02265562` - Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy	Phase 3
Completed	`NCT02083809` - Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation	N/A
Completed	`NCT02312440` - Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty	Phase 3
Completed	`NCT01895101` - The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients	Phase 4
Completed	`NCT01099475` - Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery	N/A
Completed	`NCT00990288` - The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery	Phase 4
Completed	`NCT03365999` - Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.	Phase 2
Recruiting	`NCT05550623` - Pneumatic Tourniquet Versus no Tourniquet in Transfemoral Amputation	N/A
Completed	`NCT05012202` - Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women
Completed	`NCT02311309` - Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery	N/A
Withdrawn	`NCT01712971` - Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery	N/A
Completed	`NCT01646060` - Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw	Phase 1